Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

News

Sugammadex Sodium API – CADIFA Approval by ANVISA

We are glad to announce the granting of the first CADIFA ever issued by ANVISA on the 08th of September 2021, regarding the API SUGAMMADEX SODIUM, under the requirements of the Resolution – RDC nº 359/2020. This is a landmark and a moment of great happiness for us that have worked relentlessly in partnership with ANVISA and our clients at the Pharmaceutical Industry to make this achievement come true.

Contact Us

Please fill in the following form and we'll get back to you shortly.

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit